NPPA Seeks Pricing Data on Generic Cancer Drugs Ahead of Fee Caps

International Pharmaceutical Regulatory Monitor
A A
India’s National Pharmaceutical Pricing Authority asked six manufacturers of generic cancer drugs to submit pricing data in advance of its setting price caps on the products, a move that one industry observer says was expected.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00